Backgrounds/Aims: Solid pseudopapillary neoplasm (SPPN) is typically seen in young healthy females who would likely benefit from minimally-invasive pancreatectomy (MIP). A few comparative studies have suggested that MIP is associated with favorable outcomes when compared to the open approach for SPPN. This study aims to mitigate potential selection bias by performing a matched case-control study comparing MIP vs open pancreatectomy (OP) for SPPN. Methods: We performed a single-institution retrospective electronic chart review of all patients who underwent surgery for pathologically confirmed SPPN between 2000 and 2017. A 2:1 matched comparison using age, gender, tumor size and the type of pancreatectomy was performed between OP and MIP. Results: A total of 40 patients with a median age of 40.3 years (range 16.5-64.4) and female sex predominance (n=34, 85.0%) underwent surgery during the study period. Nine patients underwent MIP. Matched comparison between 18 OP and 9 MIP demonstrated that MIP was associated with a longer median operating time (305 vs 180 min, p=0.046) and shorter median postoperative stay (6 vs 9 days, p=0.015). There were no significant differences in intraoperative blood loss, blood transfusion requirements, postoperative morbidity (including postoperative pancreatic fistula) and mortality, resection margins, lymph node yield and long-term survival. Conclusions: MIP is a safe and viable option in the management of SPPN with the benefit of a shorter postoperative length of stay at the expense of a longer operation time. There was no significant difference in oncologic outcomes between both groups of patients. 
INTRODUCTION
Solid pseudopapillary neoplasms (SPPN) are rare primary neoplasms of the pancreas comprising 1-2% of exocrine pancreatic tumors. [1] [2] [3] These were previously referred to using a variety of descriptive and eponymous names, before official nomenclature was proposed by the World Health Organization in 1996 and its classification as a borderline malignant tumor of the exocrine pancreas. [4] [5] [6] [7] Over the past two decades, there has been an increasing frequency of cases of these tumors diagnosed and reported in the literature partly due to the widespread use of cross sectional imaging and better knowledge of the condition. 7, 8 SPPN have been well characterized as a tumor predominantly seen in young females in the second and third decades of life. [1] [2] [3] [7] [8] [9] Surgical resection is routinely indicated due to its frequency of symptomatic presentations and substantial risk of metastatic progression described in up to 15% of cases. 7, [9] [10] [11] [12] Minimally invasive surgery (MIS) has gained increasing widespread acceptance for pancreatectomies, with several meta-analyses reporting improved perioperative pain control, decrease postoperative morbidity rates and shorter postoperative length of stay associated with minimally-invasive pancreatectomies (MIP). [13] [14] [15] [16] [17] [18] These attendant advantages, alongside improved scar cosmesis and decreased long-term wound complications, would potentially prove especially invaluable in the typical SPPN patient which usually comprises young healthy females with a long-life expectancy. [1] [2] [3] [7] [8] [9] Presently, there have only been a limited number of studies with small sample sizes reporting on the outcomes of MIP for SPPN [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] with an even smaller number of comparative studies published to date (20, 25, 27, 29) . In the present study to the best of our knowledge, we report the first matched case-control study comparing between MIP versus open pancreatectomy (OP) for SPPN.
MATERIALS AND METHODS
We performed a retrospective electronic chart review of all patients who underwent surgical management for path- 
RESULTS
There were a total of 40 patients who had a median Comparison between patients who underwent MIP vs OP Prior to matching, there were no significant differences in baseline demographics, perioperative characteristics and postoperative/oncologic outcomes between patients managed via OP and MIP (Tables 1, 2 Table 2 ). There were no significant differences in intraoperative blood loss and blood transfusion requirements, postoperative morbidity (including postoperative pancreatic fistula) and mortality, resection margins and lymph node yield ( Table 2 ).
The 5-year overall and disease-free survival in our cohort was 97.4% and 96.2% respectively. There were two patients with tumor recurrences at 36 (local, nodal and hepatic recurrences) and 77 (nodal recurrence) months following open distal pancreatectomy. There was no significant difference in overall and disease-free survival between patients managed via OP and MIP (Table 2) .
DISCUSSION
In the present study, the majority of our patients were young healthy females with tumors located in the neck, body and/or tail of the pancreas, which is consistent with the demographic features of the typical SPPN patient reported in existing literature. [1] [2] [3] 7 Additionally, we also found excellent long-term prognosis after complete surgical resection for SPPN with 5-yr OS rates of 96%. 2, 7, 9, 11, 36 Hence, in addition to improving short-term perioperative These studies however lack comparative analysis against SPPN managed via a conventional open approach.
In our comparative study, we found an overall and major postoperative morbidity rate of 35.0% and 10.0% respectively, which was similar to that reported previously. 
p=0.28).
We recognize the inherent limitations of our study as a single-institution retrospective review with a small sample size, largely owing to the fact that SPPN remains a rare condition. However, to the best of our knowledge, while our study represents the fifth comparative study examining open versus MIP for SPPN, it has the largest (pre-matching) study sample of all comparative studies to date, and is the first to perform a matched comparison to mitigate potential selection bias.
In conclusion, MIP is a safe and viable option in the management of SPPN with the benefit of a shorter postoperative length of stay at the expense of a longer operation time. Further studies with long-term follow-up are needed in larger patient cohorts to corroborate these findings and to determine if there are other potential longer-term benefits such as improved cosmesis and decreased long-term wound complications.
